Facebook
Twitter
LinkedIn
ForwardMCI Oncology Academic Educational Series: Lung Cancer Update, Breast Cancer Update and Fertility Preservation in Gynecologic Malignancies
Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EFGR). During this conference, Dr. Villalona-Calero will provide and update on lung cancer. Participants will gain a better understanding of the epidemiology of lung cancer.
Target Audience
Oncology Nurses, Oncologists, Radiation Oncologists, Hematology Oncologists, Nurse Practitioners, Pharmacists, Patient Navigators and other interested healthcare providers
Learning Objectives
Lung Cancer Update – Dr. Villalona-Calero
- Describe the epidemiology of lung cancer.
- Identify proper work up and management of lung cancer patients.
Breast Cancer Update – Dr. Jane Mendez
- Discuss the burden of breast cancer worldwide.
- Summarize the importance of a multidisciplinary breast cancer treatment.
Fertility Preservation in Gynecologic Malignancies – Dr. John Diaz
- Describe fertiliy-preservation options.
- Implement appropriate criteria for patient selection.
Miguel A. Villalona- Calero, M.D.
Deputy Director and Chief Scientific Officer
Miami Cancer Institute
Miguel A. Villalona-Calero, M.D., indicated that he has relevant financial relationships with commercial interest companies. He’s received grant/research support form Merck and he is a consultant with Lilly. He will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Jane E. Mendez, M.D.
Chief of Breast Surgery
Miami Cancer Institute
Jane E. Mendez, M.D. , indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
John P. Diaz, M.D.
Gynecologic Oncology
Miami Cancer Institute
John P. Diaz, M.D. , indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 3 credit hours, CE Broker Course #20-632645, by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants.
This activity has also been approved for 3 credits for Nurse Practitioners, Nurses and Pharmacists. Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
- 3.00 General certificate of attendance
- 3.00 Nurse Practitioners
- 3.00 Florida Board of Nursing
- 3.00 Florida Board of Occupational Therapy
- 3.00 Florida Board of Pharmacy
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.